Biggest News Aggregation in the World
📰 Briggs Morrison News

Page 2 - Briggs Morrison News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Briggs Morrison. Real-time updates on events, politics, business and more.

Syndax Pharmaceuticals (NASDAQ:SNDX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research report sent to investors on Thursday. The firm issued a sell rating on the stock. A number of other research firms have also commented on SNDX. B. Riley raised their price objective on shares of Syndax Pharmaceuticals from $34.00 to […]
United States William Meury Briggs Morrison Commonwealth Equity Services Syndax Pharmaceuticals Inc Analyst Recommendations For Syndax Pharmaceuticals

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Briggs Morrison Sells 52,855 Shares of Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) Director Briggs Morrison sold 52,855 shares of the firm’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $18.27, for a total transaction of $965,660.85. Following the completion of the transaction, the director now directly owns 17,836 shares of […]
Briggs Morrison Jpmorgan Chase Co News Ratings For Syndax Pharmaceuticals Daily Quarter For Syndax Pharmaceuticals Blackrock Inc York Mellon Corp

Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 1-Year Low at $19.14

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) shares reached a new 52-week low on Monday . The stock traded as low as $19.14 and last traded at $19.20, with a volume of 34822 shares traded. The stock had previously closed at $19.76. Analyst Upgrades and Downgrades Several research firms have recently weighed in on […]
United States Briggs Morrison William Meury Insider Transactions At Syndax Pharmaceuticals News Ratings For Syndax Pharmaceuticals Daily Securities Exchange Commission

Syndax Pharmaceuticals (NASDAQ:SNDX) Issues Earnings Results

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.64) EPS for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.09, Briefing.com reports. During the same quarter last year, the business posted ($0.62) EPS. Syndax Pharmaceuticals Stock Down 2.9 % SNDX traded down $0.59 during midday […]
New Zealand General New Zealand Briggs Morrison William Meury Securities Exchange Commission Wellington Management Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Syndax Pharmaceuticals (NASDAQ:SNDX) Posts Earnings Results, Beats Expectations By $0.09 EPS

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.64) EPS for the quarter, beating analysts’ consensus estimates of ($0.73) by $0.09, Briefing.com reports. During the same period in the previous year, the firm earned ($0.62) earnings per share. Syndax Pharmaceuticals Stock Performance Shares of Syndax Pharmaceuticals […]
William Meury Briggs Morrison Syndax Pharmaceuticals Inc Commonwealth Equity Services Schonfeld Strategic Advisors Earnings History For Syndax Pharmaceuticals

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $34.00 Price Target at Barclays

Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price target lifted by Barclays from $31.00 to $34.00 in a research report sent to investors on Wednesday, Marketbeat.com reports. They currently have an overweight rating on the stock. SNDX has been the subject of several other reports. StockNews.com raised shares of Syndax Pharmaceuticals to a sell […]
Hong Kong Briggs Morrison Syndax Pharmaceuticals News Ratings For Syndax Pharmaceuticals Daily Securities Exchange Commission Psagot Value Holdings Ltd

Syndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $36.00

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price objective increased by stock analysts at B. Riley from $34.00 to $36.00 in a note issued to investors on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the stock. B. Riley’s target price suggests a potential upside of 69.01% from the company’s […]
Briggs Morrison News Ratings For Syndax Pharmaceuticals Daily Syndax Pharmaceuticals Inc Exchange Traded Concepts Syndax Pharmaceuticals Peregrine Capital Management

Syndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $42.00

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its target price increased by Guggenheim from $40.00 to $42.00 in a research report issued to clients and investors on Monday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s price objective would indicate a potential upside of 94.17% from the company’s […]
United States Briggs Morrison Syndax Pharmaceuticals Metlife Investment Management Manufacturers Life Insurance Company Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Buy" from Analysts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given an average rating of “Buy” by the eight analysts that are presently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have covered the stock in the last […]
Hong Kong Briggs Morrison Institutional Trading Of Syndax Pharmaceuticals Hong Kong Ltd Insider Activity At Syndax Pharmaceuticals Syndax Pharmaceuticals Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science